SCHEMBL3828331

SCHEMBL3828331

COc1ccc(C(CC(=O)OC(C)(C)C)C(=O)O)cc1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 5/20 0.48
MTNR1B P49286 5/20 0.48
ACHE P22303 1/20 0.48
LDHA P00338 1/20 0.44
AKR1C3 P42330 3/20 0.44
AKR1C2 P52895 3/20 0.44
AKR1C1 Q04828 1/20 0.44
PTGS1 P23219 1/20 0.44
TNF P01375 4/20 0.43
PDE4A P27815 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42
PPARG P37231 1/20 0.41
PPARD Q03181 1/20 0.41
PPARA Q07869 1/20 0.41
POLB P06746 1/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8357545 0.87 MTNR1A (0.46) MTNR1AMTNR1BACHELDHAAKR1C3
SCHEMBL3832945 0.86 MTNR1A (0.45) MTNR1AMTNR1BACHELDHATNF
SCHEMBL8770891 0.83 MTNR1A (0.50) MTNR1AMTNR1BACHETNFPDE4A
SCHEMBL3451872 0.83 ACHE (0.55) ACHELDHAAKR1C3AKR1C2AKR1C1
SCHEMBL2890299 0.83 TNF (0.47) MTNR1AMTNR1BACHETNFPDE4A
SCHEMBL3828059 0.79 AKR1C3 (0.65) ACHELDHAAKR1C3AKR1C2AKR1C1
SCHEMBL1915123 0.78 SMN1; SMN2 (0.47) POLBALDH1A1MAPTTSHR
SCHEMBL6366870 0.78 PPARG (0.57) ACHELDHAAKR1C3AKR1C2AKR1C1
SCHEMBL6369033 0.78 PPARG (0.57) ACHELDHAAKR1C3AKR1C2AKR1C1
SCHEMBL1915216 0.78 SMN1; SMN2 (0.47) POLBALDH1A1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2102168-A1 ACYLAMINOPYRAZOLES FOR TREATING CARDIOVASCULAR DISEASES Bayer Schering Pharma Aktiengesellschaft (DE) 2009-09-23 EP disclosed
EP-2079708-A2 ACYL AMINOIMIDAZOLES AND ACYL AMINOTHIAZOLES Bayer HealthCare AG (DE) 2009-07-22 EP disclosed
WO-2008046527-A1 ACYLAMINOPYRAZOLES FOR TREATING CARDIOVASCULAR DISEASES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-04-24 WO disclosed
WO-2008046527-A1 ACYLAMINOPYRAZOLES FOR TREATING CARDIOVASCULAR DISEASES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-04-24 WO disclosed
WO-2008043533-A2 ACYL AMINOIMIDAZOLES AND ACYL AMINOTHIAZOLES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-04-17 WO disclosed
WO-2008043533-A2 ACYL AMINOIMIDAZOLES AND ACYL AMINOTHIAZOLES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-04-17 WO disclosed
WO-2007082666-A1 ACYLAMINOIMIDAZOLES BAYER HEALTHCARE AG (DE) 2007-07-26 WO disclosed
WO-2007082666-A1 ACYLAMINOIMIDAZOLES BAYER HEALTHCARE AG (DE) 2007-07-26 WO disclosed